People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Brainyak, Inc. | — | Other | Series A | $23.9M | $4.3M | 2010 |
| Intellicyt Corp | — | Biotechnology | Series A | $13.8M | $196.8M | 2013 |
Matt Warta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt Warta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 1 | 10 |
| Jeffrey Hinck | 1 | 10 |
| Gregory Johnson | 1 | 8 |
| Robert P. Rinek | 1 | 5 |
| George Mulhern | 1 | 5 |
| David Toth | 1 | 5 |
| Hull McKinnon | 1 | 4 |
| R. Terry Dunlay | 1 | 3 |
| Martin Payne | 1 | 3 |
| Jack T. Ball | 1 | 2 |
| Bo Saxberg | 1 | 2 |
| Joe Zell | 1 | 2 |
| Jeffrey P. Hinck | 1 | 2 |
| Tim Ray Petersen | 1 | 1 |
| Dave M. Sibley | 1 | 1 |
| Robert M. Wengel | 1 | 1 |
| Chuck P. Cullen | 1 | 1 |
| Robert Rinek | 1 | 1 |
| Robert Wengel | 1 | 1 |
| H. Raymond Radosevich | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.